Effects of Microtox on Facial Skin Quality, Fine Wrinkles, and Texture

PHASE1CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

September 3, 2024

Primary Completion Date

August 29, 2025

Study Completion Date

September 16, 2025

Conditions
Skin AgingSkin Wrinkling
Interventions
DRUG

PrabotulinumtoxinA-Xvfs

Each vial of prabotulinumtoxinA-xvfs contains 100 units of product, and it will be reconstituted with 5 mL of bacteriostatic saline solution. 20 units of this intervention will only be injected to the left side of subject faces - intramuscularly to the corrugator supercilii and intradermally to the forehead region.

DRUG

IncobotulinumtoxinA

Each vial of incobotulinumtoxinA contains 100 units of product, and it will be reconstituted with 5 mL of bacteriostatic saline solution. 20 units of this intervention will only be injected to the right side of subject faces - intramuscularly to the corrugator supercilii and intradermally to the forehead region.

DRUG

saline solution (placebo)

As a placebo treatment, saline solution will be injected on the right side of the glabellar lines and forehead region instead of an active neuromodulator. The saline solution has no therapeutic effect and is used as a control to compare the results against the active treatment.

Trial Locations (1)

91105

K. Kay Durairaj, MD, A Medical Corp., Pasadena

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Evolus, Inc.

INDUSTRY

lead

Kalpna Kay Durairaj, MD, FACS

OTHER

NCT06604832 - Effects of Microtox on Facial Skin Quality, Fine Wrinkles, and Texture | Biotech Hunter | Biotech Hunter